Clinical Trial Update: DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating escitalopram to prevent depression in patients with acute coronary syndrome; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Bispebjerg Hospital | Conditions: Depression | Phase 4 | Status: UNKNOWN